Seeing Is Believing
Millendo Therapeutics's activity chart (see below) currently has 11 price targets and 10 ratings on display.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 271.25 days.
Most recent stock forecast was given by from LADENBURG on 06-Jan-2021. First documented stock forecast 16-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2020
$5
5 years 8 months 7 days ago
(06-Jan-2021)
2/2 (100%)
$-21.85 (-81.38%)
592
Buy Since 11-Mar-2020
$25
6 years 5 months 7 days ago
(06-Apr-2020)
1/1 (100%)
$-73.7 (-74.67%)
26
Buy Since 07-Feb-2020
$20
$16.71 (507.90%)
$23
6 years 5 months 20 days ago
(24-Mar-2020)
2/2 (100%)
$-76.15 (-79.20%)
215
Buy Since 16-Jul-2019
$25
$21.71 (659.88%)
7 years 1 months ago
(13-Aug-2019)
2/2 (100%)
$-81.5 (-76.53%)
252
What is MLND (Millendo Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MLND (Millendo Therapeutics)?
Which analyst has the most public recommendations on MLND (Millendo Therapeutics)?
Which analyst is the currently most bullish on MLND (Millendo Therapeutics)?
Which analyst is the currently most reserved on MLND (Millendo Therapeutics)?